Revised SPC: Jardiance (empagliflozin) film-coated tablets

SPC has been updated to note that it should not be used for treatment of patients with type 1 diabetes, with clinical trial data showing its use as an adjunct to insulin was associated with increased diabetic ketoacidosis occurrence with common frequency compared to placebo.

Source:

electronic Medicines compendium